A PHASE I MULTICENTER STUDY OF THE SAFETY AND IMMUNOGENICITY OF MN RGP120/HIV-1 VACCINE GIVEN EITHER ALONE OR IN COMBINATION WITH IIIB RGP120/HIV-1 VACCINE IN HEALTHY ADULT SUBJECTS (NOTE: ORIGINAL STUDY EXTENDED ONLY FOR PATIENTS PREVIOUSLY ENROLLED ON VEU 009):